Evidence map›Paper›PMID 28883821›Full record

ArticleFrontiers in immunology2017

Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer.

Linling He, Xiaohe Lin, Natalia de Val, Karen L Saye-Francisco, Colin J Mann, Ryan Augst, Charles D Morris, Parisa Azadnia, Bin Zhou, Devin Sok and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. A VScience advances · 2020
    Article
  8. Article
  9. Computational tools for modern vaccine development.Human vaccines & immunotherapeutics · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Linling HeDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Xiaohe LinDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Natalia de ValDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States.
Karen L Saye-FranciscoDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Colin J MannDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Ryan AugstDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Charles D MorrisDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Parisa AzadniaDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Bin ZhouDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, United States.
Devin SokDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Gabriel OzorowskiDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States.
Andrew B WardDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States.
Dennis R BurtonDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Jiang ZhuDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Scripps Research Institute · USInternational AIDS Vaccine Initiative · USRagon Institute of MGH, MIT and Harvard · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AHMED, RAFI · 2012 to 2018
$131.5M
Structural studies of native-like SOSIP trimersP01AI110657 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOORE, JOHN P · 2015 to 2024
$35.4M
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogensP01AI124337 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI ZHU, JIANG · 2016 to 2020
$12.2M
Rational design and B cell responses of HIV epitope vaccinesR01AI129698 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ZHU, JIANG · 2017 to 2021
$3.2M
Structural Biology of HIV-1 Neutralizing Antibody Targets for Vaccine DesignR01AI084817 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 2009 to 2013
$3.2M
Novel trimer platform on particles as HIV vaccine candidatesR56AI125078 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ZHU, JIANG · 2016 to 2016
$600k
Structure and dynamics of native HIV-1 envelope trimersR56AI084817 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 2015 to 2015
$593k
NIAID NIH HHS P01 AI110657NIAID NIH HHS P01 AI124337NIAID NIH HHS R01 AI084817NIAID NIH HHS R01 AI129698NIAID NIH HHS R56 AI084817NIAID NIH HHS R56 AI125078NIAID NIH HHS UM1 AI100663
6 · The paper itself

Abstract

Germline precursors and intermediates of broadly neutralizing antibodies (bNAbs) are essential to the understanding of humoral response to HIV-1 infection and B-cell lineage vaccine design. Using a native-like gp140 trimer probe, we examined antibody libraries constructed from donor-17, the source of glycan-dependent PGT121-class bNAbs recognizing the N332 supersite on the HIV-1 envelope glycoprotein. To facilitate this analysis, a digital panning method was devised that combines biopanning of phage-displayed antibody libraries, 900 bp long-read next-generation sequencing, and heavy/light (H/L)-paired antibodyomics. In addition to single-chain variable fragments resembling the wild-type bNAbs, digital panning identified variants of PGT124 (a member of the PGT121 class) with a unique insertion in the heavy chain complementarity-determining region 1, as well as intermediates of PGT124 exhibiting notable affinity for the native-like trimer and broad HIV-1 neutralization. In a competition assay, these bNAb intermediates could effectively compete with mouse sera induced by a scaffolded BG505 gp140.681 trimer for the N332 supersite. Our study thus reveals previously unrecognized lineage complexity of the PGT121-class bNAbs and provides an array of library-derived bNAb intermediates for evaluation of immunogens containing the N332 supersite. Digital panning may prove to be a valuable tool in future studies of bNAb diversity and lineage development.

Indexed as

antibody phage displayB-cell lineage developmentbroadly neutralizing antibodiesHIV-1 vaccine designnative-like trimernext-generation sequencing

Identifiers

PMID28883821
PMCPMC5573810
OpenAlexW2749398329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.